Oncology Times

Lymphoma & Leukemia Resource Center

Featured Articles

This collection of content will continually bring you the latest news, research and FDA approvals relating to leukemia and lymphoma.

 

For more articles, visit the Article Library

Genomic Analysis Unravels Complexities of DLBCL 

The majority of patients with diffuse large B-cell lymphoma (DLBCL) can be treated effectively. However, people whose disease recurs face a shortage of good options, especially because the disease is driven by a complicated mix of genetic alterations.

Read More

Attacking Diffuse Large B-Cell Lymphoma at the Source 

One of the driving forces behind non-Hodgkin lymphomas is the overactivation of a receptor on the surface of B cells.

Read More

Study Revises Molecular Classification for DLBCL

In a new study, researchers identified genetic subtypes of diffuse large B-cell lymphoma (DLBCL) that could help explain why some patients with the disease respond to treatment and others don’t.  

Read More

Loading